Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29288676 | 0.98 | KMT2A (0.63) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| SCHEMBL4638377 | 0.86 | KMT2A (0.60) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| SCHEMBL616678 | 0.84 | ALDH1A1 (0.64) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| SCHEMBL6398309 | 0.83 | KMT2A (0.71) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| SCHEMBL5875894 | 0.82 | ALDH1A1 (0.52) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| SCHEMBL74700 | 0.82 | MAPK1 (0.52) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| Hydrochloric Acid SCHEMBL5875896 | 0.82 | ALDH1A1 (0.62) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| Methane SCHEMBL28308571 | 0.81 | KMT2A (0.69) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| Hydrochloric Acid SCHEMBL29079546 | 0.81 | KMT2A (0.69) | KMT2AALDH1A1CYP3A4TDP1ALOX15 | |
| SCHEMBL2330920 | 0.81 | ALDH1A1 (0.49) | KMT2AALDH1A1CYP3A4TDP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110475785-A | The selection method of peptide compounds and its manufacturing method, screening composition and peptide compounds | FUJIFILM CORP | 2019-11-19 | — | — | CN | disclosed |
| CN-109422725-A | Drugs for prostate cancer | 北京美倍他药物研究有限公司 | 2019-03-05 | — | — | CN | disclosed |
| CN-109293585-A | A method of halobenzamides rapid synthesis quinazolinones are utilized under microwave condition in water phase | 云南师范大学 | 2019-02-01 | — | — | CN | disclosed |
| US-20050182040-A1 | Benzamide derivatives | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2005-08-18 | — | — | US | disclosed |
| EP-1500643-A1 | BENZAMIDE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2005-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182040-A1 | Benzamide derivatives | ROCK1, ROCK2, NHERF1 | KMT2A 1307/4885ALDH1A1 2454/4885CYP3A4 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.